Nationwide recall: Migraine relief medication
(WJW) -The U.S. Food and Drug Administration has announced a nationwide recall of migraine relief medication sold through Amazon.
According to the alert, Aurobindo Pharma USA, Inc., on behalf of AuroHealth, is voluntarily recalling the pain medication because it’s missing the manufacturer label which would include required drug facts and patient usage information.
Recall on produce items sold at Walmart, Aldi
“There is significant risk of misuse which could result in permanent liver damage if consumers exceed the recommended dose, combine use with excessive consumption of alcohol or are allergic to the active ingredient which could be life-threatening,” reads the notfication.
The recall applies to one lot of Healthy Living Migraine Relief, Acetaminophen 250mg, Aspirin (NSAID) 250mg & Caffeine 65mg tablets.
Richard Simmons’ team shares his last photo
The company said the product was shipped to customers nationwide starting in January 2024.
Here’s what consumers should check for:
NDC No. | Product Name, strength, and pack | Lot number | Expiry |
|---|---|---|---|
58602-882-21 | Acetaminophen 250mg; Aspirin 250mg; | AC2523005A | June-2025 |
The product will be in a white unlabeled bottle from the Manufacturer (AuroHealth) bearing only an Amazon identifying sticker.
Tablets are described “White to off-white, capsule-shaped, biconvex film-coated tablet debossed with “T” on one side and “57” on the other side.”
The product is packaged in 100 count bottles.
Anyone with questions should contact Aurobindo Pharma USA, Inc. at:
1-866-850-2876 (Option 2), 24 hours per day, 7 days per week; or
CLICK HERE to read the full recall alert.
Copyright 2024 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
For the latest news, weather, sports, and streaming video, head to Fox 8 Cleveland WJW.
